Company intelligence / Profile preview

Inventia Healthcare

Mumbai, Maharashtra, Indiainventiahealthcare.com ↗
Ownership
Private
Employees
~749
Development stage
Other
01

Overview

Inventia Healthcare is a leading Indian pharmaceutical company specializing in innovative oral solid dosage formulations and advanced drug delivery systems for both regulated and emerging markets. It has a strong track record in developing patient-friendly medicines with global regulatory approvals.

Therapeutic areas
RheumatologyCardiovascularNeurology
Modalities
Small moleculeOral solid dosage forms (tablets, capsules, granules, pellets)NutraceuticalsInjectables (recent vertical)
Industry
Biotech
02

Partnerships

Amerigen Pharmaceuticals Limited ("Amerigen") – collaboration for US ANDA commercializationFPP – licensing & supply agreement for ANDA products

Beyond the preview

Go deeper on Inventia Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inventia Healthcare.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call